BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, February 15, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 17, 2012
View Archived Issues
New potential analgesics disclosed by Novartis
Read More
GSK presents novel ITK/TSK inhibitors
Read More
Exelixis discovers new PI3Kdelta inhibitors
Read More
Novel inhibitors of neurotransmitter reuptake developed in Japan
Read More
Preclinical data support clinical testing of AVEO antibody
Read More
Addex discloses encouraging data on lead oral small molecule
Read More
Multitargeted antimitotic drug achieves tumor regression in vivo
Read More
Two new promising oncology programs presented
Read More
Regeneron Pharmaceuticals generates new anticancer antibody
Read More
Scientists describe analgesic effects of novel cannabinoid CB2 receptor agonists
Read More
First patient dosed in pivotal Arikace study
Read More
QRxPharma completes phase I trials of MoxDuo CR
Read More
New potential pancreatic cancer biomarker identified at H. Lee Moffitt Center
Read More
Vanda Pharmaceuticals acquires tachykinin NK1 receptor antagonist
Read More
Proteros and Eisai launch research collaboration
Read More
Merck & Co. gains worldwide rights to anticancer conjugate
Read More
UCB reports on phase III axial spondyloarthritis trial
Read More
Another milestone reached in phase IIa Cx-611 study
Read More
Novartis seeking approval in Japan of Glivec for new indication
Read More
Conformetrix enters first collaboration agreement
Read More
Dainippon Sumitomo Pharma seeks approval in Japan for Surepost in combination therapy
Read More
Eisai set to launch GABA(A) receptor agonist in Japan
Read More
Daiichi Sankyo launches Ranmark in Japan
Read More
Otsuka Pharmaceutical plans launch of new Abilify formulation
Read More
ThromboGenics resubmits BLA for ocriplasmin
Read More
Inspiration Biopharmaceuticals files for approval of rFIX product
Read More
